• Advising Crossroads, a private equity fund manager, in the sales process of eight franchised Benelux hotels to Easy Plc for approximately 145 million euros.
  • Advising Collagen Matrix, Inc., a global leader in regenerative medicine and a Linden Capital Partners portfolio company, with the acquisition of Polyganics, B.V. a medical technology company that develops and manufactures bioresorbable medical devices.
  • Advising Majorel (a global provider of next-generation end-to-end customer experience (CX) solutions for digital-native and vertical leading brands and listed on the Euronext Amsterdam) on the acquisition of IST Networks (a full-service CX Technology Services provider).
  • Advising Box Inc. (a cloud content management services company) on its acquisition of SignRequest (a cloud-based electronic signature company).
  • Advising Fortissimo Capital (a leading private equity fund in Israel,) on its acquisition of a majority stake of Sanquin Plasma Products B.V. (a plasma-derived medicine producer).
  • Advising IMF Bentham Limited (listed on the Australian Securities Exchange) on the acquisition of Omni Bridgeway Holding. We have also assisted with the capital raise in order to finance this acquisition.
  • Assisting Algeco Group on its acquisition of several Dutch BUKO entities, including BUKO Huisvesting and BUKO Bouw & Winkels.
  • Advising Dechra Pharmaceuticals on the EUR340m acquisition of AST Farma and Le Vet.
  • Advising Accruent BC Holdings on its acquisition of all issued and outstanding shares in the capital of BlueCielo Group B.V. from Gilde.
  • Advising G Square Capital on its acquisition of Duo Med Group from ABN Amro Participaties.
  • Advising NH Hotels on the EUR155m sale of NH Barbizon Palace to DEKA, including on the lease agreement for leaseback of the hotel.